Related Experiment Video
Updated: Dec 23, 2025

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation
Published on: January 6, 2016
The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis
Daqian Xu1,2, Zheng Wang3, Yan Xia4,5
1Department of Hepatobiliary and Pancreatic Surgery and Zhejiang Provincial Key Laboratory of Pancreatic Disease of The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. xudaqian@zju.edu.cn.
Abstract:
Cancer cells increase lipogenesis for their proliferation and the activation of sterol regulatory element-binding proteins (SREBPs) has a central role in this process. SREBPs are inhibited by a complex composed of INSIG proteins, SREBP cleavage-activating protein (SCAP) and sterols in the endoplasmic reticulum. Regulation of the interaction between INSIG proteins and SCAP by sterol levels is critical for the dissociation of the SCAP-SREBP complex from the endoplasmic reticulum and the activation of SREBPs1,2. However, whether this protein interaction is regulated by a mechanism other than the abundance of sterol-and in particular, whether oncogenic signalling has a role-is unclear. Here we show that activated AKT in human hepatocellular carcinoma (HCC) cells phosphorylates cytosolic phosphoenolpyruvate carboxykinase 1 (PCK1), the rate-limiting enzyme in gluconeogenesis, at Ser90. Phosphorylated PCK1 translocates to the endoplasmic reticulum, where it uses GTP as a phosphate donor to phosphorylate INSIG1 at Ser207 and INSIG2 at Ser151. This phosphorylation reduces the binding of sterols to INSIG1 and INSIG2 and disrupts the interaction between INSIG proteins and SCAP, leading to the translocation of the SCAP-SREBP complex to the Golgi apparatus, the activation of SREBP proteins (SREBP1 or SREBP2) and the transcription of downstream lipogenesis-related genes, proliferation of tumour cells, and tumorigenesis in mice. In addition, phosphorylation of PCK1 at Ser90, INSIG1 at Ser207 and INSIG2 at Ser151 is not only positively correlated with the nuclear accumulation of SREBP1 in samples from patients with HCC, but also associated with poor HCC prognosis. Our findings highlight the importance of the protein kinase activity of PCK1 in the activation of SREBPs, lipogenesis and the development of HCC.
Insights
Activated AKT in cancer cells phosphorylates PCK1, which then activates SREBP proteins, promoting lipogenesis, tumor growth, and poor prognosis in hepatocellular carcinoma (HCC).
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Cancer cells rely on increased lipogenesis for proliferation, a process centrally regulated by sterol regulatory element-binding proteins (SREBPs).
- SREBP activation is normally inhibited by a complex involving INSIG proteins, SCAP, and sterols in the endoplasmic reticulum.
- The precise regulatory mechanisms of this complex, particularly concerning oncogenic signaling, remain incompletely understood.
Purpose of the Study:
- To investigate the role of oncogenic signaling, specifically activated AKT, in regulating SREBP activation and lipogenesis in hepatocellular carcinoma (HCC).
- To elucidate the molecular mechanism by which activated AKT influences the INSIG-SCAP interaction and subsequent SREBP activation.
Main Methods:
- Utilized human hepatocellular carcinoma (HCC) cells and mouse models.
- Investigated protein phosphorylation events using specific antibodies and cellular localization studies.
- Analyzed the interaction between INSIG proteins and SCAP.
- Assessed SREBP activation, lipogenesis-related gene transcription, cell proliferation, and tumorigenesis.
- Correlated molecular findings with clinical data from HCC patients.
Main Results:
- Activated AKT in HCC cells phosphorylates phosphoenolpyruvate carboxykinase 1 (PCK1) at Ser90.
- Phosphorylated PCK1 translocates to the endoplasmic reticulum and phosphorylates INSIG1 and INSIG2, disrupting their interaction with SCAP.
- This disruption leads to SCAP-SREBP complex translocation to the Golgi, SREBP activation, and increased lipogenesis-related gene expression.
- PCK1, INSIG1, and INSIG2 phosphorylation correlates with SREBP1 nuclear accumulation and predicts poor HCC prognosis.
- Inhibition of this pathway suppressed tumor growth in mice.
Conclusions:
- Oncogenic AKT signaling activates SREBP-mediated lipogenesis in HCC through PCK1-dependent phosphorylation of INSIG proteins.
- This pathway is crucial for tumor cell proliferation and tumorigenesis in HCC.
- PCK1's kinase activity is highlighted as a key regulator in SREBP activation, lipogenesis, and HCC development.
- Targeting this pathway presents a potential therapeutic strategy for HCC.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Cell Specific Gene Expression
PI3K/mTOR/AKT Signaling Pathway
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin Secretory Vesicles
cAMP-dependent Protein Kinase Pathways

